1Y Close · As of Aug 26, 2026
ViGenCell operates in the Professional Services sector.
Legal name: ViGenCell Inc.
In fiscal year 2024, ViGenCell (308080) reported revenue of 279 million KRW.
Operating profit was -15.3 billion KRW and net income was -14.1 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 117.7 billion KRW, with a P/B of 2.69.
These figures can be verified in the DART filing (receipt no. 20260318001532).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2024 | 279M | -15.3B | -14.1B |
| 2023 | — | -20.1B | -17.9B |
| 2022 | — | -18.2B | -17.4B |
| 2021 | — | -13.1B | -11.1B |
| 2020 | — | -7.9B | -10.5B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |